| Sunday, March 20, 2005 |
| Time |
Session |
Presenters |
| 12:00-2:00pm |
Workshop 1: Operational Aspects of Biosafety and Biocontainment |
Chair:
W. Emmet Barkley
Particiapants:
Cathy Wilhelmsen, USAMRIID
Mike Dennis, Porton Down
Sean G. Kaufman, Rollins Sch. of Publ. Hlth., Emory Univ.
Richard Henkel, CDC |
|
| 12:00-2:00pm |
Workshop 2: Environmental Monitoring and Decontamination
(Developed in Cooperation with AOAC International) |
Chair:
Mark R. Coleman, Eli Lilly
|
| |
Introduction
|
Mark R. Coleman, Eli Lilly |
| |
Involvement of AOAC International in Biodefense: Committed to Worldwide Confidence in Analytical Results
|
Mark R. Coleman, Eli Lilly |
| |
Efficacy Tests for Sporicides: Improving the AOAC Sporicidal Activity Test and the Evaluation of Quantitative Test Methods
|
Stephen F. Tomasino, Ph.D., U.S. EPA |
| |
Nanoemulsion Decontamination for Biological Agents
|
Tarek Hamouda, M.D., Ph.D., NanoBio Inc. |
| |
Formladehyde Fumigation and Vapour Phase Hydrogen Peroxide: Efficacy against Bacterial and Viral Surrogates
|
Allan Bennett, M.Sc., Ctr. for Emergency Preparedness and Response, Health Protection Agency |
| |
A New Spin on Decontamination Agents: Gels, Mists, and Solid-Water Particles
|
Paula A. W. Krauter, Lawerence Livermore Nat. Lab. |
|
| 2:00-4:00pm |
Workshop 3: FDA Workshop: The Critical Path, BioShield, and Medical Countermeasure Development |
Chair:
Boris D. Lushniak, M.D., MPH, U.S. FDA |
| |
Critical Path: The Big Picture
|
Janet Woodcock, U.S. FDA |
| |
The Critical Path, the "Animal Rule", and Their Impact on the Development of Vaccines against Pneumonic Plague
|
Karen Meysick, CBER, FDA |
| |
Nonhuman Primate Models for Pneumonic Plague
|
Lewis Schrager, CDER, FDA |
| |
Pharmokinetics and Animal Models
|
Frank Pelsor, CDER, FDA |
| |
Tools to Navigate the "Critical Path" for Development of In Vitro Diagnostics |
Roxanne Shively, CDRH, FDA |
|
| 2:00-4:00pm |
Workshop 4: Opportunities for Research Collaborations and Product Development in the Former Soviet Union |
Chair:
Michael Balady, Defense Threat Reduction Agency
Participants:
Michael Balady, Defense Threat Reduction Agency
Sue Partridge, BETEP
Maria Douglas, U.S. BioIndustry Initiative
|
|
| 2:00-4:00pm |
Workshop 5: An Overview of Biodefense Activities in DHS and in NIAID |
Chairs:
John Vitko, Jr., U.S. Dept. of Homeland Security
Carole Heilman, NIAID, NIH |
| |
Implementing the NIAID BioDefense Research Agenda
|
Michael G. Kurilla, M.D., Ph.D., DMID, NIAID, NIH, DHHS |
| |
Overview of the DHS Biodefense Program
|
John Vitko, Jr., U.S. Dept. of Homeland Security |
| |
The DHS "Bio Centers" |
Carol Linden, Ph.D., U.S. Dept. of Homeland Security |
|
| 6:00-8:30pm |
Opening Session |
|
| |
Opening Remarks |
Gail H. Cassell, Ph.D., Chair Biodefense Program Cmte. |
| |
Keynote: Project Bioshield: The Need, the Legislation, Gaps in Legislation, and Practical Application
|
Philip K. Russell, M.D., Albert B. Sabin Vaccine Inst. |
| |
Panel Discussion: Translating Basic Research into Real Products: Different Perspectives |
Moderator:
Noreen Hynes, M.D., M.P.H., U.S. Dept. of Health and Human Services |
| |
Academic |
Arturo Casadevall, M.D., Ph.D., Albert Einstein Coll. of Med. |
| |
Biotechnology |
J. Leighton Read, M.D., Alloy Ventures |
| |
Big PhRMA |
James Matthews, Ph.D., Sanofi Pasteur |
| |
Department of Health and Human Services |
Monique Mansoura, M.D., U.S. Dept of Health and Human Services |
| |
Current Congressional Proposals |
Frank Gottron, Ph.D., Congressional Res. Service, Washington, DC |
| |
|
Brad Smith, Ph.D., Univ. of Pittsburgh |
| |
|
W. Seth Carus, Center for Counterproliferation Research |
|
| 8:30-10:00pm |
Opening Reception |
Open to all Registrants |
| Monday, March 21, 2005 |
| Time |
Session |
Presenters |
| 8:30am-7:00pm |
Monday Posters on Display |
|
|
| 8:30-9:30am |
Keynote: Prions: Novel Threat Agents |
Stanley B. Prusiner, M.D., Univ. of California, San Francisco |
|
| 9:30am-12:00pm |
Symposium: Risk Assessment of Biothreats: Application of Forensics and Diagnostics |
Chairs:
Clare M. Fraser, Ph.D., The Inst. for Genomic Res.
Tim Brooks, Ctr. for Emergency Preparedness & Response, Porton Down, UK |
| |
Will the Real Anthrax Step Forward: the Dangers of Environmental Studies
|
Tim Brooks, Ctr. for Emergency Preparedness & Response, Porton Down, UK |
| |
Application of Microbial Forensics |
Jacques Ravel, Ph.D., The Inst. for Genomic Res. |
| |
Diagnostics for Highly Dangerous Viruses
|
Georg Pauli, Robert Koch Inst. |
| |
Field and Point of Care Detection |
Charles Daitch, Ph.D., Akonni Biosystems Inc. |
| |
Novel Approaches to Viral Bioweapons Defense
|
Vishwanath R. Lingappa, M.D., Ph.D., Prosetta Corp. |
| |
The TIGER Biosensor: Applications in Biodefense, Epidemiology, and Emerging Infectious Disease Surveillance |
David J. Ecker, Ph.D., Ibis Therapeutics |
|
| 1:30-2:30pm |
Keynote: Successful Integration of R&D, Regulatory, Commercial, and Manufacturing Capabilities to Bring Major Vaccines to Market |
William Gruber, M.D., Wyeth Vaccines |
|
| 2:30-5:00pm |
Symposium: Aerobiology and Animal Models: Implications for Threat Agents and Product Development |
Chairs:
Louise Pitt, Ph.D., USAMRIID
Ann Williams, HP Porton Down |
| |
Overview of the State of the Art Aerobiology in Biodefense
|
Louise Pitt, Ph.D., USAMRIID |
| |
Dose and Biologic Response: Importance in Aerosol Models of Disease
|
Chad Roy, Ph.D., USAMRIID |
| |
Example of Aerosol Model Development: The Viral Encephalopathies
|
Douglas S. Reed, Ph.D. USAMRIID |
| |
Advanced Aerosol Technologies for Deliver of Drugs and Vaccines in Biodefense
|
David Edwards, Harvard Univ. |
| |
Appropriateness of Animal Models: Consideration of Species Differences |
Rick Lyons, Ph.D., Univ. of New Mexico |
| 5:00-7:00pm |
Presentations by Poster Authors and Reception |
|
| Tuesday, March 22, 2005 |
| Time |
Session |
Presenters |
| 8:30am-7:00pm |
Tuesday Posters on Display |
|
|
| 8:30-9:30am |
Keynote: The Food Supply and Biodefense: The Next Frontier of the Food Safety Agenda |
Michael Osterholm, Ph.D., M.P.H., Univ. of Minnesota, Minneapolis |
|
| 9:30am-12:00pm |
Symposium: Food and Agroterrorism |
Chairs:
Kaye Wachsmuth, Ph.D.
Michael L. Perdue, Ph.D., WHO, CDC |
| |
Novel Approaches for Detection/Characterization of Foodborne Pathogens
|
Thomas A. Cebula, Ph.D., FDA
|
| |
Crop and Pre-Harvest Threats to Food Security
|
Suresh D. Pillai, Ph.D., Texas A&M Univ. |
| |
Protection of Livestock from Highly Transmissible Diseases: Novel Outbreak Intervention Tools
|
Luis L. Rodriguez, D.V.M., Ph.D., USDA |
| |
Animal Models and Assessing Virulence/Pathogenicity of Foodborne Select Agents
|
Carole Bolin, D.V.M, Coll. of Vet. Med., Michigan State Univ. |
| |
Protecting the Food Supply from Botulinum Neurotoxin |
James D. Marks, M.D., Ph.D., Univ. of California, San Francisco |
|
| 1:30-2:30pm |
Keynote: Biomedical Research and Public Health: Practical Aspects of Biosafety, Biosecurity, and Balancing the Risks |
Ruth L. Berkelman, M.D., Emory Univ. |
|
| 2:30-4:30pm |
Round Table: Promoting Responsible Stewardship in the Biosciences: Different Perspectives
|
Chair:
Frederick A. Murphy, Ph.D., D.V.M., Univ. of California, Davis |
| |
Round Table 1: Understanding the Current Challenges for Research, Public Health, and Sustaining International Collaboration |
|
| |
The Challenge to Government/Academic Research Interactions (virological viewpoint)
|
Peter Jahrling, Ph.D., NIH/NIAID |
| |
The Challenge of Maintaining Free Exchange of Reagents and Agents from Culture Collections
|
Erko Stackebrandt, Sc.D., DSMZ |
| |
The Challenge from the WHO Perspective |
Ottorino Cosivi, WHO |
| |
|
Shanna Nesby-O'Dell, DVM, MPH, CDC |
| |
Round Table 2: Guidelines and Principles for Professional Conduct and Oversight |
David A. Relman, Stanford Univ.
Lawrence Kerr, Ph.D., Office of Sci. and Tech. Policy
Lee Ann Thomas, USDA
Charles Brokopp, DrPH, CDC
Michael Oborne, Ph.D., Organisation for Economic Co-operation and Dev. |
|
| 5:00-7:00pm |
Presentations by Poster Authors and Reception |
|
| Wednesday, March 23, 2005 |
| Time |
Session |
Presenters |
| 8:30-9:30am |
Keynote: Poxvirus Replication and Pathogenesis: Increased Understanding Leads to Design of Better Vaccines and New Therapeutics |
|
|
| 9:30am-12:00pm |
Symposium: Advances in Molecular Pathogenesis of Threat Agents |
Chair:
Hans-Dieter Klenk, Inst. of Virology, Philipps-Univ.
Susan C. Straley, Ph.D., Univ. of Kentucky |
| |
Genomic and Proteomic Analysis of Anthrax/Host Interaction
|
Philip Hanna, Ph.D., Univ. of Michigan Med. Sch. |
| |
From Type III Secretion to Probing Innate Defenses against Plague
|
Susan C. Straley, Ph.D., Univ. of Kentucky |
| |
Biology of Nipah and Hendra Viruses: Implications for Development of Vaccines and Therapeutics
|
Christopher C. Broder, Ph.D., Uniformed Services Univ. of Health Sci. |
| |
Seeking Shared Mechanisms Among Viral Hemorrhagic Fevers |
Mike Bray, M.D., NIAID, NIH |
|
| 1:30-2:30pm |
Keynote: Influenza and Bird Flu: The Ultimate Threats |
Anthony S. Fauci, M.D., NIAID, NIH |
|
| 2:30-5:00pm |
Symposium: Flu Pandemic Preparedness: The Realities |
Chairs:
W. Ian Lipkin, M.D., Columbia Univ.
Linda Lambert, Ph.D., NIH |
| |
New Approaches to Vaccine Development
|
Richard J. Webby, Ph.D., St. Jude Children's Res. Hosp. |
| |
Old and New Therapeutics: The Challenges
|
Simon P. Tucker, Ph.D., Biota Holdings Ltd. |
| |
Field Application of New Diagnostics
|
W. Ian Lipkin, M.D., Columbia Univ. |
| |
The Pandemic Preparedness Plan |
Bruce Gellin, M.D., M.P.H., U.S. Dept. of Health and Human Services |
